| 2026-08-11 | Press release | Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates |
| 2026-08-10 | Presentation | Corporate Overview August 2026 |
| 2026-06-29 | Press release | Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies |
| 2026-05-14 | Press release | Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) |
| 2026-05-13 | Press release | Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer |
| 2026-05-07 | Press release | Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates |
| 2026-05-04 | Press release | Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) |
| 2026-03-19 | Press release | Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates |
| 2026-03-05 | Press release | Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosi |
| 2026-03-02 | Press release | Zura Bio to Participate in Upcoming Investor Conferences |
| 2026-02-27 | Press release | Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase |
| 2026-02-23 | Press release | Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Boar |
| 2026-02-04 | Press release | Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit |
| 2026-01-21 | Press release | Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer |
| 2026-01-12 | Press release | Zura Bio Reports Business Updates and Outlook for 2026 |
| 2025-03-25 | Press release | Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates |
| 2024-11-07 | Press release | Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates |
| 2024-08-13 | Press release | Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights |
| 2024-05-09 | Press release | Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights |
| 2024-03-28 | Press release | Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive O |
| 2023-11-13 | Press release | Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights |
| 2023-08-14 | Press release | Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights |
| Press release | JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited |
| Press release | JATT Acquisition Corp Announces Planned Transfer of Listing to NASDAQ in Connection with its Proposed Business Combinati |